Avanos Medical (AVNS) Intangibles (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Intangibles data on file, last reported at $114.7 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles rose 7.0% year-over-year to $114.7 million; the trailing twelve-month figure through Mar 2026 stood at $114.7 million (up 7.0% YoY), and the FY2025 full-year result was $117.8 million, up 4.9% from the prior year.
• Intangibles retreated to $114.7 million in Q1 2026, from $117.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $264.9 million in Q2 2022 to a low of $29.6 million in Q3 2023.
• A 5-year average of $175.8 million and a median of $220.1 million in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles slumped 88.56% in 2023 and soared 643.58% in 2024, its largest moves.
• Tracing AVNS's Intangibles over 5 years: stood at $234.2 million in 2022, then advanced by 2.26% to $239.5 million in 2023, then tumbled by 53.11% to $112.3 million in 2024, then advanced by 4.9% to $117.8 million in 2025, then slipped by 2.63% to $114.7 million in 2026.
• Business Quant data shows AVNS's Intangibles at $114.7 million in Q1 2026, $117.8 million in Q4 2025, and $122.0 million in Q3 2025.